Literature DB >> 20674479

Chikungunya fever in Singapore: acute clinical and laboratory features, and factors associated with persistent arthralgia.

M K Win1, A Chow, F Dimatatac, C J Go, Y S Leo.   

Abstract

BACKGROUND: In Singapore, the first local outbreak of chikungunya was reported in January 2008, followed by a larger outbreak occurred in August 2008. During the initial outbreak period, a strict containment strategy was adopted and all chikungunya PCR-confirmed cases were isolated and hospitalised at the designated national outbreak management centre.
OBJECTIVES: To detail daily clinical and laboratory features of chikungunya cases during acute illness, and determine factors associated with persistent arthralgia at week 6. STUDY
DESIGN: Prospective cohort study of patients with PCR-confirmed chikungunya infection and hospitalised within 5 days of illness onset, from 1st August to 10th November 2008. Post-hospital discharge, patients were followed up at the specialist outpatient clinic, and assessed for arthralgia at week 6 of illness.
RESULTS: Of the 97 patients in the study, the most common presenting symptoms were fever (89.7%) and arthralgia (87.6%). Mean nadir leukocyte and platelet counts were 3.5(SD 1.9) × 10(9)/L and 165(SD 42) × 10(9)/L respectively. Of the 39 patients who were evaluated at week 6, 14 (35.9%) had persistent arthralgia. Those with persistent arthralgia tended to be females (p = 0.003), and had a lower peak creatinine level (p = 0.036) than those without. Peak viral load (p = 0.664), and duration of fever (p = 0.056) and viremia (p = 0.55) respectively, were not significantly different between those with persistent arthralgia and those without.
CONCLUSIONS: This study details the daily clinical and laboratory features of chikungunya patients during acute illness. Those with persistent arthralgia tended to be females, who had significantly lower peak creatinine level.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674479     DOI: 10.1016/j.jcv.2010.07.004

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  46 in total

1.  Chikungunya Virus Disease among Travelers-United States, 2014-2016.

Authors:  Nicole P Lindsey; J Erin Staples; Marc Fischer
Journal:  Am J Trop Med Hyg       Date:  2018-01-01       Impact factor: 2.345

2.  How many patients with post-chikungunya chronic inflammatory rheumatism can we expect in the new endemic areas of Latin America?

Authors:  A J Rodriguez-Morales; J A Cardona-Ospina; W Villamil-Gómez; A E Paniz-Mondolfi
Journal:  Rheumatol Int       Date:  2015-06-05       Impact factor: 2.631

3.  Occurrence of Chronic Stage Chikungunya in the General Population of Martinique during the First 2014 Epidemic: A Prospective Epidemiological Study.

Authors:  Brieg Couzigou; Anne Criquet-Hayot; Emilie Javelle; Sandrine Tignac; Edith Mota; François Rigaud; Alizé Alain; Odile Troisgros; Sandrine Pierre-Francois; Sylvie Abel; Rishika Banydeen; André Cabié
Journal:  Am J Trop Med Hyg       Date:  2018-05-24       Impact factor: 2.345

Review 4.  Chikungunya in the region of the Americas. A challenge for rheumatologists and health care systems.

Authors:  Carlos Pineda; Roberto Muñoz-Louis; Carlo V Caballero-Uribe; Diego Viasus
Journal:  Clin Rheumatol       Date:  2016-08-24       Impact factor: 2.980

5.  Ebola virus disease sequelae: a challenge that is not going away.

Authors:  Janet T Scott; Malcolm G Semple
Journal:  Lancet Infect Dis       Date:  2017-01-14       Impact factor: 25.071

6.  Clinical Manifestations Associated with Peripheral Joint Involvement in Patients with Acute Chikungunya Virus Infection.

Authors:  Mariangelí Arroyo-Ávila; Amanda Cabán; Enid J García-Rivera; Marisela Irizarry-Pérez; Hilda Torres; Héctor Gorbea; Luis M Vilá
Journal:  Am J Trop Med Hyg       Date:  2017-01-30       Impact factor: 2.345

7.  Manifestations of Atypical Symptoms of Chikungunya during the Dhaka Outbreak (2017) in Bangladesh.

Authors:  Iztiba Mallik Deeba; Md Mahbub Hasan; Abdullah Al Mosabbir; Md Hasanul Banna Siam; Muhammad Sougatul Islam; Enayetur Raheem; Mohammad Sorowar Hossain
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

8.  Viperin restricts chikungunya virus replication and pathology.

Authors:  Terk-Shin Teng; Suan-Sin Foo; Diane Simamarta; Fok-Moon Lum; Teck-Hui Teo; Aleksei Lulla; Nicholas K W Yeo; Esther G L Koh; Angela Chow; Yee-Sin Leo; Andres Merits; Keh-Chuang Chin; Lisa F P Ng
Journal:  J Clin Invest       Date:  2012-11-19       Impact factor: 14.808

9.  Longitudinal analysis of the human antibody response to Chikungunya virus infection: implications for serodiagnosis and vaccine development.

Authors:  Yiu-Wing Kam; Wendy W L Lee; Diane Simarmata; Sumitro Harjanto; Terk-Shin Teng; Hugues Tolou; Angela Chow; Raymond T P Lin; Yee-Sin Leo; Laurent Rénia; Lisa F P Ng
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

10.  Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor.

Authors:  Angela Chow; Zhisheng Her; Edward K S Ong; Jin-miao Chen; Frederico Dimatatac; Dyan J C Kwek; Timothy Barkham; Henry Yang; Laurent Rénia; Yee-Sin Leo; Lisa F P Ng
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.